Assessment of genomic profiling in patients with colorectal cancer treated in community oncology practices

被引：0
|
作者：
Cosgrove, David
Paul, Emily
Harrell, Robyn
Espirito, Janet L.
Robert, Nicholas J.
Oliver, Robert J.
机构：
[1] Compass Oncol, Vancouver, WA USA
[2] Ontada, Durham, NC USA
[3] Ontada, Las Colinas, TX USA
[4] Ontada, Irving, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15538
引用
收藏
页数：1
相关论文
共 50 条
  • [1] TREATMENT PATTERNS AND OUTCOMES IN METASTATIC COLORECTAL CANCER (MCRC) PATIENTS TREATED IN A COMMUNITY ONCOLOGY SETTING
    Cartwright, T. H.
    Pan, I
    Wen, L.
    Wadlow, R. C.
    Rembert, D.
    Seal, B.
    VALUE IN HEALTH, 2014, 17 (03) : A69 - A70
  • [2] Expression and genomic profiling of colorectal cancer
    Cardoso, J.
    Boer, J.
    Morreau, H.
    Fodde, R.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2007, 1775 (01): : 103 - 137
  • [3] Guideline adherence rates of chemotherapy treatment for colon cancer patients treated in US community oncology practices
    Wang, Z.
    Bergstrom, K. A.
    Aksamit, I.
    Tuscher, L.
    Lam, T.
    Tom, B. S.
    Baker, C. G.
    Whitlock, K. B.
    Ansari-Jaberi, Z.
    Mayo, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Survival Outcomes of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer Patients Treated in US Community Oncology
    Cartwright, Thomas H.
    Yim, Yeun Mi
    Yu, Elaine
    Chung, Hsingwen
    Halm, Melissa
    Forsyth, Michael
    CLINICAL COLORECTAL CANCER, 2012, 11 (04) : 238 - 246
  • [5] Gender-specific genomic profiling in metastatic colorectal cancer patients treated with 5-fluorouracil and oxaliplatin
    Gordon, Michael A.
    Zhang, Wu
    Yang, Dongyun
    El-Khourery, Anthony
    Nagashima, Fumio
    Lurje, Georg
    Labonte, Melissa
    Wilson, Peter
    Sherrod, Andy
    Ladner, Robert D.
    Lenz, Heinz-Josef
    PHARMACOGENOMICS, 2011, 12 (01) : 27 - 39
  • [6] Genomic profiling as predictor of toxicity in patients with advanced colorectal cancer treated with platinum-based chemotherapy.
    Park, DJ
    Yun, J
    Yang, DY
    Iqbal, S
    Press, O
    Groshen, S
    Gordon, M
    Zhang, W
    Lenz, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 276S - 276S
  • [7] Prevalence of ERBB alterations in colorectal cancer patients using genomic profiling
    Kundranda, M. N.
    Wang, M.
    Hall, D. W.
    Hoag, J.
    Alyaqoub, F.
    Noel, P.
    Szelinger, S.
    Udhane, S. S.
    Ozols, A. A.
    Lobello, J. R.
    Baehner, F. L.
    Thakkar, S. G.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S696 - S697
  • [8] Feasibility study of genomic biomarker profiling for patients with metastatic colorectal cancer
    Smith, Bradley L.
    Breitfeld, Philip
    Cubino, Jennifer
    Weigman, Victor
    Richards, Donald P.
    Chung, Ki Y.
    CANCER RESEARCH, 2014, 74 (19)
  • [9] Real-world treatment patterns and effectiveness among patients with metastatic colorectal cancer treated with ziv-aflibercept in community oncology practices in the USA
    Jasmina I. Ivanova
    Kimberly R. Saverno
    Jennifer Sung
    Mei Sheng Duh
    Chen Zhao
    Sean Cai
    Francis Vekeman
    Aaron Peevyhouse
    Ravinder Dhawan
    Charles S. Fuchs
    Medical Oncology, 2017, 34
  • [10] Real-world treatment patterns and effectiveness among patients with metastatic colorectal cancer treated with ziv-aflibercept in community oncology practices in the USA
    Ivanova, Jasmina I.
    Saverno, Kimberly R.
    Sung, Jennifer
    Duh, Mei Sheng
    Zhao, Chen
    Cai, Sean
    Vekeman, Francis
    Peevyhouse, Aaron
    Dhawan, Ravinder
    Fuchs, Charles S.
    MEDICAL ONCOLOGY, 2017, 34 (12)
12345